Drug Shortage Report for TWINRIX

Last updated on 2017-12-06
Report ID 16553
Drug Identification Number 02230578
Brand name TWINRIX
Common or Proper name Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED HEPATITIS B SURFACE ANTIGEN
Strength(s) 720UNIT 20MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-07-18
Estimated end date 2017-12-07
Actual end date 2017-12-04
Shortage status Resolved
Updated date 2017-12-06
Company comments Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.
Health Canada comments
Company contact information 1-800-387-7374